Issue Date: June 4, 2012
Takeda To Buy Brazil’s Multilab
Takeda Pharmaceutical has agreed to acquire Brazil’s Multilab Indústria e Comércio de Produtos Farmacêuticos for $249 million up front and up to $20 million in milestone payments. In 2011, Multilab had sales of $70 million, primarily of branded generic and over-the-counter drugs. Takeda already manufactures prescription and OTC products in the country. According to the Japanese company, buying 24-year-old Multilab will make it one of the top 10 pharmaceutical companies in Brazil.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society